Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-07-09
1995-04-25
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
544267, 544270, 544271, A61K 3152, C07D47304
Patent
active
054099358
ABSTRACT:
The use of xanthine derivatives for the treatment of secondary nerve cell damage and functional disorders after cranio-cerebral traumas (CCT)
The use of xanthine derivatives of the formula I ##STR1## and of their physiologically tolerable salts, in which R.sup.1 is oxoalkyl, hydroxyalkyl or alkyl, R.sup.2 is hydrogen or alkyl and R.sup.3 is hydrogen, alkyl, oxoalkyl or an alkyl having up to 6 carbon atoms, whose carbon chain is interrupted by an oxygen atom, for the production of pharmaceuticals for the treatment of disorders which can occur after cranio-cerebral traumas is described.
REFERENCES:
patent: 4275064 (1981-06-01), Bodor et al.
patent: 4289776 (1981-09-01), Mohler et al.
patent: 4291037 (1981-09-01), Brenner et al.
patent: 4719212 (1988-01-01), Goto et al.
patent: 4833146 (1989-05-01), Gebert et al.
patent: 4868186 (1989-09-01), Franzone et al.
Chao et al., Activated Microglia Mediate Neuronal Cell Injury Via a Nitric Oxide Mechanism, J. Immunol., 1992 (Abstract).
Woodroofe et al., Detection of Interleukin-1 and Interleukin-6 in Adult Rat Brain, Following Mechanical Injury, by in Vivo Microdialysis: Evidence of For Microglia in Cytokine Production, J. Neuroimmunol, 1991 (Abstract).
Giulian D., Microglia, Cytokines, and Cytotoxins: Modulators of Cellular Responses After Injury to the Central Nervous System, EOS Riv. Immunol. Immunofarm, 1990 (Abstract).
Giulian et al., Microglial Mitogens Are Produced in the Developing and Injured Mammalian Brain, J. Cell Biol., 1991 (Abstract).
Giulian et al., Brain Glia Release Factors With Opposing Actions Upon Neuronal Survival, J. Neurosci, 1993 (Abstract).
Giulian, Ameboid Microglia as Effectors of Inflammation in the Central Nervous System, J. Neurosci. Res., 1987 (Abstract).
Frei et al., Immunobiology of Microglial Cells, Ann. New York Acad. Sci., 1988 (Abstract).
Adams et al., Head Injury, Greenfield's Neuropathology, Fourth Edition, pp. 85-124, 1984.
Lister, "Fused Pyrimidines" Part II, Purines, The Oxo-(Hydroxy-) and Alkoxypurines, pp. 223-225, 1971.
Lister, "Fused Pyrimidines" Part II, Purines, Chapter II, Syntheses From Pyrimidines, pp. 31, 35 and 55, 1971.
Krauch et al., Reaktionen Der Organischen Chemie, Traurr, p. 590, 1971.
Glia, "Functional Plasticity of Microglia: A Review", vol. 1, pp. 301-307, 1988.
E. Pfenninger, Das Schadel-Hirn-Trauma, Anaesthesiologie und Intensivmedizin, vol. 203, Bergmann (Editor), Springer-Verlay, Berlin, 1988.
Banati et al., "Respiratory burst activity in brain macrophages: a flow cytometric study on cultured rat microglia", Neuropathology and Applied Neurobiology, vol. 17, pp. 223-230, 1991.
Head Injury: Hope Through Research, NIH Publication No. 84-2478, Aug. 1984.
DeLeo et al., "Protection Against Ischemic Brain Damage Using Propentofylline in Gerbils," Stroke, vol. 19, No. 12, pp. 1535-1539, 1988.
Stefanovich et al., "Effect of Propentofylline on the Biochemical Lesion of the Rat Brain in Aluminium-Induced Neurotoxidity," Metobolic Brain Disease, vol. 5, No. 1, pp. 7-17, 1990.
Mrsulja et al., "Propentofylline and Postischemic Brain Edema: Relation to Na+-K+-ATPase Activity," Drug Development Research, vol. 6, No. 4, pp. 339-344, 1985.
Ganser et al., "Effect of Pentoxifylline on Cerebral Edema in Cats," Neurology, vol. 24, No. 5, pp. 487-493, 1974.
Shinoda et al., "Stimulation of Nerve Growth Factor Synthesis/Secretion By Propentofylline in Cultured Mouse Astroglial Cells," Biochemical Pharmacology, vol. 39, No. 11, pp. 1813-1816, 1990.
Mann et al., "The Synthesis and Properties of 1:7-Dialkyl Xanthines," J. Chem. Soc., pp. 751-760, 1945.
Robert Berkow "The Merck Manual", published by Merck, Sharp & Dohme Research Laboratories, pp. 1334-1337, 1982.
Gebert Ulrich
Grome John J.
Kittner Barbara
Rudolphi Karl
Schubert Hans-Peter
Hoechst Aktiengesellschaft
Shah Mukund J.
Sripada P. K.
LandOfFree
Xanthine derivatives for the treatment of secondary nerve cell d does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Xanthine derivatives for the treatment of secondary nerve cell d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Xanthine derivatives for the treatment of secondary nerve cell d will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1568025